A recent enforcement action by the California Attorney General against a leading healthcare publisher (order PDF) underscores a critical reality: compliance with privacy laws like the California Consumer Privacy Act (CCPA) is an ongoing, strategic responsibility shared across the digital advertising ecosystem. At DeepIntent, we don’t view enforcement actions as isolated cases but as roadmaps. […]
DeepIntent has been officially certified by Disney for live sports and entertainment advertising, helping redefine what’s possible in real-time, streaming-first media. Disney recognized the DeepIntent platform for its ability to meet the complex demands of live advertising. As healthcare marketers seek more agile and audience-centric ways to connect with patients and providers, this partnership opens […]
Despite years of progress in healthcare innovation, too many patients in North America still face barriers to care that stem not from biology, but from geography, income, and systemic inequities. Across North America, millions of people live in “care deserts” with limited or no access to hospitals, pharmacies, or primary care providers. These individuals, many […]
Last week, Cannes Lions 2025 brought together the global advertising industry for a week of high-profile programming, creative celebration, and perhaps most importantly, meaningful connection. Panels offered insight into where marketing is headed, and other insights emerged among leaders between sessions. Here are six key takeaways that reflect the shifting priorities, new challenges, and emerging […]
Last week, a new bill called the “End Prescription Drug Ads Now Act” was introduced in Congress, aiming to ban nearly all direct-to-consumer (DTC) pharmaceutical advertising. While the legislation has sparked headlines, its chances of becoming law are slim due to constitutional concerns and bipartisan disagreement. Still, it reflects growing attention to the pharmaceutical industry […]
In pharmaceutical marketing, data is the foundation for strategy, targeting, and measurement. As marketing becomes increasingly data-driven—and more data becomes available than ever before—the question facing pharma brands is often which data to use. That’s where data choice comes into play. What is Data Choice? Data choice refers to the ability to select from […]
AdLab 2025’s final panel brought together top healthcare marketing leadership to discuss the groundbreaking, women-led innovations shaping our industry, and how women leaders are strengthening their company cultures. DeepIntent Chief Revenue Officer Lisa Kopp Johnson moderated the panel, which featured Nicole Hamlin, Group Director, Integrated Planning at Butler/Till; Andrea Palmer, Chief Executive Officer at Publicis […]
In an age when information overload and medical misinformation are rampant, ensuring equitable access to accurate, timely health information has never been more urgent. The disparities in healthcare, driven by cultural, socioeconomic, and geographic divides, are well-documented. But as the latest research reveals, healthcare advertising is uniquely positioned to help close these gaps and improve […]
One of the most exciting conversations at AdLab 2025 was the panel, “AI in Health Marketing: Real-World Strategies, Use Cases, and Ethics.” As AI continues to reshape how healthcare marketers target, optimize, and engage, panelists cut through the noise to explore what’s actually working and what’s most promising. Moderated by DeepIntent Chief Technology Officer Anton […]
Not all optimization is created equal, especially in healthcare advertising, where a marketer’s level of precision can directly impact patient outcomes. As our industry evolves, real-time, impression-level optimization is setting a new benchmark for relevance, efficiency, and clinical impact. The Landscape: Broad vs. Precision Optimization Traditionally, healthcare campaigns have been optimized at the ad […]
Research shows that a cross-channel strategy is essential to the pharma media mix, especially as TV viewership shifts from linear to streaming. For healthcare marketers, consolidating campaigns across channels unlocks the potential for better frequency control, more consistent messaging, and greater campaign efficiency. To quantify the impact of cross-channel consolidation, a leading agency and its […]
Pharmaceutical advertising is a critical part of the information landscape for today’s healthcare providers (HCPs). According to a study conducted by MAGNA Media Trials and DeepIntent, 92% of doctors say pharma ads increase awareness and drive meaningful conversations with their patients. This receptivity presents a major opportunity for healthcare brands to deepen their impact, and […]
As upfront season kicks off, media buyers across industries are recalibrating their video strategies, determining both how much to spend and where to spend it. For pharmaceutical marketers, that charge increasingly leads to connected TV (CTV). At AdLab 2025, marketing leaders took the stage to share how CTV is reshaping their media plans. Jeff Collins, […]
In a vibrant session at AdLab 2025, a panel of industry leaders explored how endemic publishers are adapting to a rapidly evolving programmatic landscape. The discussion featured Damon Basch, VP and Head of Digital Media at Veradigm; Tom Carr, SVP of Media and Data Strategy at Everyday Health; Francis D’Hondt, SVP of Addressable Health at […]
Pharma advertisers have long relied on TV for its unmatched scale and storytelling power. But as viewing habits evolve and demand for measurable results grows, more advertisers are integrating Connected TV (CTV) into their upfront strategies. The annual TV upfronts—once centered on broad buys and fixed commitments—are being reimagined through a programmatic lens, with CTV […]